Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Adenoma, Islet Cell × Everolimus × Clear all

Phase

Phase 2 3 Phase 3 1 Phase 2/3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Tuberous Sclerosis 2 Autistic Disorder 2 Uterine Neoplasms 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Intellectual Disability 1 Hamartoma Syndrome, Multiple 1 Gastroenteropancreatic Neuroendocrine Tumors 1 Gallbladder Neoplasms 1 Adenoma, Islet Cell 1

Interventions

Oxaliplatin 1 Leucovorin 1 Fluorouracil 1 Everolimus 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06943755 2026-02-27

STELLAR-311

Exelixis

Phase 2/3 Recruiting

Adenoma, Islet Cell, Neoplasm Metastasis, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡